Friday, June 19, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

SpaceX’s $20 Billion Bond Plan and $401 Analyst Target Collide as First Week Rally Fades

SiterGedge by SiterGedge
June 19, 2026
in Analysis, Nasdaq, Space
0
SpaceX Stock
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

The initial frenzy around SpaceX’s public listing has cooled sharply. After two straight days of losses, the stock slid more than 6% on Friday to approximately $178, retreating from the all-time high of $225.64 set just days earlier. The pullback wiped out roughly 8.3% of value in the run-up to the June 19 holiday, which market observers attribute to a natural exhaustion following a blistering debut from the $135 IPO price.

Retail investors, who received about 20% of the offering, have been net sellers this week. According to Vanda Research, net purchases slumped to just over $9 million — a dramatic deceleration from the buying frenzy that drove the company’s market capitalization as high as $3 trillion at one point. The stock now trades at a $2.4 trillion valuation, making SpaceX the world’s sixth most valuable company.

While equity traders take profits, the bond market is sending a very different signal. Fitch Ratings awarded SpaceX an investment-grade rating of BBB+, citing the company’s stranglehold on commercial spaceflight. S&P followed with its own upgrade, highlighting the 12 million subscribers currently using Starlink. The double thumbs-up comes as SpaceX prepares a $20 billion bond offering, with JPMorgan and Goldman Sachs leading the placement. Proceeds will replace a bridge loan used to finance the acquisition of AI startup xAI.

The bullish bond reception aligns with an aggressive analyst call that arrived on June 18. Arete Research initiated coverage with a Buy rating and a price target of $401 per share — more than double the $185 closing price at the time. Oppenheimer also chimed in, raising its target to $250 after factoring in the billion-dollar purchase of Anysphere, a software firm expected to accelerate internal development.

Should investors sell immediately? Or is it worth buying SpaceX?

Underpinning these optimistic projections is a business that commands over 80% of global satellite mass launched into orbit since 2023. That dominance extends from launch services to Starlink, the broadband constellation that Morgan Stanley sees as the primary revenue driver for the rest of the decade. The Starship rocket program adds a second growth lever, promising to slash per-kilogram costs and open new frontiers such as orbital data centers and AI computing in space.

Yet SpaceX’s expansion comes at a staggering price. In the first quarter of 2026, the company generated $4.69 billion in revenue but posted a net loss of $4.28 billion — far wider than the roughly $500 million deficit in the same period last year. Since early 2023, SpaceX has accumulated an estimated $13 billion in losses, almost entirely from research and development spending on Starship and artificial intelligence. Analysts characterize the spending as foundational for future recurring income, even as it weighs on near-term earnings.

The next market catalyst is less than a month away. After 15 trading days, SpaceX shares will become eligible for inclusion in the Nasdaq 100, a milestone that typically triggers inflows from passive funds that track the index. Combined with the bond sale and the eventual unwinding of insider lock-ups, the coming weeks will test whether the company can sustain its $2.4 trillion valuation — or whether the profit-taking has further to run.

Ad

SpaceX Stock: Buy or Sell?! New SpaceX Analysis from June 19 delivers the answer:

The latest SpaceX figures speak for themselves: Urgent action needed for SpaceX investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 19.

SpaceX: Buy or sell? Read more here...

Tags: SpaceX
SiterGedge

SiterGedge

Related Posts

Rocket Lab USA Stock
Industrial

Rocket Lab’s New Phase: Index Entry and Robotics M&A Converge to Reshape the Investment Thesis

June 19, 2026
Vital Farms Stock
Analysis

Vital Farms Faces Twin Storms: Legal Investigation and Institutional Flight

June 19, 2026
Kuros Biosciences Stock
Analysis

Kuros Biosciences: Revenue Surges 72% But Shares Sink to 52-Week Low

June 19, 2026
Next Post
ServiceNow Stock

ServiceNow's Q1 Revenue Jumps 22% as AI Bet Pays Off, but Armis Price Tag Weighs on Margins

XPeng Stock

XPeng's X9 Dominates Norwegian Range Test, but European Launch Fails to Ignite Stock

Outlook Therapeutics Stock

Outlook Therapeutics' July 16 Shareholder Vote to Decide Nasdaq Fate as FDA Decision Looms on July 29

Recommended

Tyler Stock

Institutional Investors Recalibrate Stakes in Government Software Provider

5 months ago
Trinet Stock

Trinet Stock: A Study in Contradictions Amid Steep Decline

10 months ago
Strategy Stock

Conflicting Signals Leave Strategy Investors at a Crossroads

9 months ago
Vulcan Energy Stock

Vulcan Energy Powers Europe’s Lithium Independence Drive

7 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kuros Biosciences: Revenue Surges 72% But Shares Sink to 52-Week Low

Medtronic’s Asian Push and Portfolio Reshuffle Fail to Lift Stock from Its Lows

Cerebras Races Into First Earnings Report After Back-to-Back Double-Digit Gains

Outlook Therapeutics’ July 16 Shareholder Vote to Decide Nasdaq Fate as FDA Decision Looms on July 29

XPeng’s X9 Dominates Norwegian Range Test, but European Launch Fails to Ignite Stock

ServiceNow’s Q1 Revenue Jumps 22% as AI Bet Pays Off, but Armis Price Tag Weighs on Margins

Trending

Rocket Lab USA Stock
Industrial

Rocket Lab’s New Phase: Index Entry and Robotics M&A Converge to Reshape the Investment Thesis

by Rodolfo Hanigan
June 19, 2026
0

Monday will bring Rocket Lab a structural shift that no single launch can match. The stock joins...

Vital Farms Stock

Vital Farms Faces Twin Storms: Legal Investigation and Institutional Flight

June 19, 2026
Core Lithium Stock

Core Lithium’s Twin Catalyst: A$290M Funding and Bynoe Acquisition Target 2026 Production

June 19, 2026
Kuros Biosciences Stock

Kuros Biosciences: Revenue Surges 72% But Shares Sink to 52-Week Low

June 19, 2026
Medtronic Stock

Medtronic’s Asian Push and Portfolio Reshuffle Fail to Lift Stock from Its Lows

June 19, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rocket Lab’s New Phase: Index Entry and Robotics M&A Converge to Reshape the Investment Thesis
  • Vital Farms Faces Twin Storms: Legal Investigation and Institutional Flight
  • Core Lithium’s Twin Catalyst: A$290M Funding and Bynoe Acquisition Target 2026 Production

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com